文献速递水电解质与酸碱慢性肾脏病

高钾血症与死亡率、心血管事件、住院及ICU入住的相关性:基于人群的回顾性队列研究

Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort.
PubMed 文献 · Kidney Int Rep · 2021-03-17

在新发高钾血症(血钾≥5.0 mmol/L)与非高钾血症患者间进行1:1倾向评分匹配后,高钾血症与全因死亡、心血管事件、短期死亡、住院及ICU入住风险增加独立相关,敏感性分析(血钾≥5.5 mmol/L)结果不变。

要点

  • 高钾血症(血钾≥5.0 mmol/L)与全因死亡风险增加15%独立相关(HR 1.15)。
  • 高钾血症与心血管事件风险增加20%独立相关(HR 1.20)。
  • 高钾血症与住院(OR 1.71)和ICU入住(OR 3.48)风险显著增加相关。

核心结论

  • 高钾血症是全因死亡、心血管事件、住院及ICU入住的独立危险因素。

研究设计与样本

  • 对新发高钾血症(血钾≥5.0 mmol/L)与非高钾血症患者进行1:1倾向评分匹配,匹配样本177,082人。
  • 采用多变量Cox比例风险回归模型评估高钾血症与死亡的关系,次要结局包括心血管事件、住院和ICU入住,敏感性分析采用血钾≥5.5 mmol/L定义高钾血症。

主要发现

  • 93,667例新发高钾血症患者中,36%有糖尿病,28%有慢性肾脏病,21%有心力衰竭。
  • 在倾向评分匹配样本中,高钾血症与全因死亡风险增加相关(HR 1.15,95%CI 1.13-1.18,P<0.001)。
  • 高钾血症与心血管事件风险增加相关(HR 1.20,95%CI 1.14-1.26,P<0.001)。
  • 高钾血症与短期死亡风险增加相关(OR 1.29,95%CI 1.24-1.34,P<0.001)。
  • 高钾血症与住院(OR 1.71,95%CI 1.68-1.74)和ICU入住(OR 3.48,95%CI 3.34-3.62,P<0.001)风险增加相关,敏感性分析结果不变。

关键数值与推荐

  • 高钾血症定义:血清钾≥5.0 mmol/L;敏感性分析定义:血清钾≥5.5 mmol/L。
  • 匹配样本量:177,082人(1:1倾向评分匹配)。
  • 全因死亡HR 1.15(95%CI 1.13-1.18,P<0.001);心血管事件HR 1.20(95%CI 1.14-1.26,P<0.001);短期死亡OR 1.29(95%CI 1.24-1.34,P<0.001);住院OR 1.71(95%CI 1.68-1.74);ICU入住OR 3.48(95%CI 3.34-3.62,P<0.001)。

临床怎么用

  • 在CKD、糖尿病或心力衰竭患者中应重视高钾血症的监测与管理,因其与不良临床结局独立相关。
  • 血钾≥5.0 mmol/L即可视为风险升高的阈值,需评估并干预以降低死亡、心血管事件及住院风险。

局限性

  • 回顾性队列研究设计,可能存在残余混杂。
  • 使用行政数据库,血钾检测可能非所有患者常规进行,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hyperkalemia is a common, potentially life-threatening condition in patients with chronic kidney disease (CKD). We studied the association between hyperkalemia and mortality, cardiovascular events, hospitalizations, and intensive care unit (ICU) admissions. METHODS: We performed a retrospective cohort study using administrative databases in Manitoba, Canada. All adults (≥18 years of age) with potassium tests between January 2007 and December 2016 were included, with follow-up until March 31, 2017. Propensity score matching was performed among patients with de novo hyperkalemia (serum potassium ≥ 5.0 mmol/l) and patients who were nonhyperkalemic. The association between hyperkalemia and normokalemia and mortality was assessed using multivariate Cox proportional hazards regression models, adjusting for patient characteristics in a 1:1 propensity score-matched sample. Secondary outcomes included cardiovascular events, hospitalizations, and ICU admissions. A sensitivity analysis was performed with hyperkalemia defined as serum potassium ≥ 5.5 mmol/l. RESULTS: Of 93,667 patients with de novo hyperkalemia, 36% had diabetes mellitus (DM), 28% had CKD, and 21% had heart failure (HF). In the propensity score-matched sample of 177,082 individuals, hyperkalemia was associated with an increased risk for all-cause mortality (hazard ratio [HR] 1.15 [95% confidence interval {CI} 1.13-1.18], P < 0.001), cardiovascular events (HR 1.20 [95% CI 1.14-1.26], P < 0.001), short-term mortality (odds ratio [OR] 1.29 [95% CI 1.24-1.34], P < 0.001), hospitalizations (OR 1.71 [95% CI 1.68-1.74]), and ICU admissions (OR 3.48 [95% CI 3.34-3.62], P < 0.001). Findings were unchanged when a threshold of serum potassium ≥ 5.5 mmol/l was used. CONCLUSION: Hyperkalemia was an independent risk factor for all-cause mortality, cardiovascular events, hospitalizations, and ICU admissions. This finding expands our understanding of important clinical outcomes associated with hyperkalemia.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Hougen I, Leon SJ, Whitlock R, et al. Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort. Kidney Int Rep. 2021. PMID: 34013109. doi:10.1016/j.ekir.2021.02.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。